Shares rose as much as 6.9% in European morning trading Tuesday, in a session with broad-based losses across European stocks ...

Bayer has removed a protein therapeutic for hypertension and a treatment for diabetic neuropathic pain from its phase 1 ...

Bayer is forecast to report quarterly earnings before interest, taxes, depreciation and amortization excluding special items of 3.93 billion euros, according to ...

Class action lawyers are seeking $675 million for their role in negotiating a $7.25 billion proposal to settle current ​and ...

By Ludwig Burger FRANKFURT, May 12 (Reuters) - Bayer on Tuesday reported a 9% increase in quarterly operating profit that was ...

The initiative also includes digital marketplaces, satellite-based insights for risk protection, and AI-powered advisory, ...

Bayer has appealed a verdict awarding $1.25M to a man who was diagnosed with non-Hodgkin lymphoma after years of exposure to glyphosate in Roundup.

Bayer has agreed to acquire Perfuse Therapeutics for up to $2.45 billion, in a deal designed to broaden the buyer’s ophthalmology pipeline with Perfuse’s sole pipeline drug and two clinical phase ...

The US Supreme Court gave Bayer AG a mixed reception on its bid to stop tens of thousands of lawsuits claiming its Roundup herbicide should have been labeled as a cancer risk.

Since Roche launched its long-acting eye disease medicine Vabysmo in 2022, Bayer and Regeneron have seen the impact on sales of their rival treatment Eylea, with the U.S. biotech taking a bigger hit.

Bayer Aktiengesellschaft ( BAYRY) Q1 2026 Earnings Call May 12, 2026 4:00 AM EDT Well, good morning, everybody, and welcome to our media update for the first quarter 2026. Many thanks for joining us ...

Bayer is recalling Afrin travel-size nasal spray bottles missing a required child-safety warning; most were sold at ...